Concord Medical Services Holdings Limited (CCM) Income Statement Analysis

See more : Sphere Entertainment Co. (SPHR) Income Statement Analysis – Financial Results

Complete financial analysis of Concord Medical Services Holdings Limited (CCM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Concord Medical Services Holdings Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.

You may be interested

Concord Medical Services Holdings Limited (CCM)

Industry: Medical - Care Facilities

Sector: Healthcare

Website: https://www.concordmedical.com

About Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue	537.40M	472.09M	485.63M	223.01M	198.36M	190.90M	330.98M	455.04M	616.49M	606.88M	563.12M	455.65M	450.13M	389.52M	292.44M	171.79M
Cost of Revenue	614.01M	624.49M	542.53M	209.93M	214.19M	171.14M	232.98M	286.54M	353.34M	274.56M	217.66M	164.52M	159.42M	122.70M	87.56M	45.60M
Gross Profit	-76.61M	-152.41M	-56.90M	13.08M	-15.83M	19.76M	98.00M	168.50M	263.15M	332.32M	345.47M	291.13M	290.71M	266.82M	204.88M	126.19M
Gross Profit Ratio	-14.26%	-32.28%	-11.72%	5.87%	-7.98%	10.35%	29.61%	37.03%	42.69%	54.76%	39.77%	49.68%	64.58%	68.50%	70.06%	73.46%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	308.71M	311.16M	347.75M	294.82M	315.13M	291.85M	237.65M	205.91M	132.95M	53.58M	84.51M	61.11M	114.40M	70.01M	29.82M	18.87M
Selling & Marketing	56.30M	61.48M	53.68M	25.76M	30.24M	21.72M	43.61M	70.09M	112.82M	95.10M	104.67M	53.91M	37.45M	17.15M	7.68M	5.50M
SG&A	386.38M	372.64M	401.42M	320.58M	345.38M	313.57M	281.25M	276.00M	245.77M	148.67M	189.17M	115.02M	151.85M	87.16M	37.50M	24.37M
Other Expenses	0.00	0.00	0.00	8.50M	76.09M	5.43M	28.60M	61.12M	23.13M	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	386.38M	372.64M	401.42M	329.08M	421.46M	319.01M	309.85M	337.13M	268.89M	148.67M	189.17M	103.39M	151.85M	87.16M	37.50M	24.37M
Cost & Expenses	1.00B	997.13M	943.95M	539.01M	635.66M	490.14M	542.83M	623.67M	622.23M	423.23M	406.83M	267.92M	311.27M	209.86M	125.06M	69.96M
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.60M	13.36M	7.87M	948.00K	430.00K
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.45M	7.45M	6.89M	7.46M
Depreciation & Amortization	118.83M	123.19M	94.46M	70.79M	56.35M	45.02M	89.45M	127.81M	157.25M	198.07M	179.64M	148.58M	120.64M	109.69M	78.17M	38.13M
EBITDA	-344.16M	-401.86M	-363.86M	-236.72M	-304.85M	-248.79M	-93.80M	20.31M	174.63M	381.72M	335.94M	332.63M	-161.31M	291.93M	246.29M	140.38M
EBITDA Ratio	-48.65%	-123.11%	-68.24%	-92.56%	-132.90%	-110.82%	-21.79%	15.01%	11.01%	36.40%	21.26%	32.51%	33.82%	46.79%	57.56%	81.72%
Operating Income	-462.99M	-525.05M	-458.32M	-316.00M	-437.29M	-299.24M	-211.86M	-168.63M	-5.74M	183.65M	156.30M	184.05M	138.86M	179.67M	167.38M	101.83M
Operating Income Ratio	-86.15%	-111.22%	-94.38%	-137.89%	-220.45%	-156.76%	-64.01%	-37.06%	-0.93%	30.26%	17.92%	30.71%	30.85%	46.12%	57.24%	59.27%
Total Other Income/Expenses	-92.61M	-314.85M	-70.92M	-125.65M	46.22M	74.00M	-42.04M	-35.97M	489.00K	-8.00M	-12.03M	-2.91M	-3.73M	-4.88M	-6.16M	578.00K
Income Before Tax	-555.59M	-839.90M	-529.24M	-441.65M	-391.08M	-225.25M	-253.90M	-204.60M	-5.25M	175.65M	144.27M	181.14M	-165.03M	174.79M	161.22M	102.40M
Income Before Tax Ratio	-103.39%	-177.91%	-108.98%	-198.04%	-197.15%	-117.99%	-76.71%	-44.96%	-0.85%	28.94%	17.36%	29.41%	-36.66%	44.87%	55.13%	59.61%
Income Tax Expense	24.57M	70.91M	6.57M	37.62M	38.99M	34.05M	31.79M	60.49M	74.03M	80.85M	63.84M	54.25M	46.32M	43.87M	36.40M	23.34M
Net Income	-297.66M	-489.66M	-271.43M	-309.99M	-307.05M	-234.88M	-284.32M	-261.87M	-78.30M	124.71M	85.89M	123.24M	-215.00M	129.40M	124.83M	79.07M
Net Income Ratio	-55.39%	-103.72%	-168.98%	-300.39%	-278.54%	-188.18%	-85.90%	-57.55%	-12.70%	16.35%	13.34%	27.05%	-47.77%	33.22%	42.69%	46.03%
EPS	-68.14	-112.09	-187.85	-153.35	-127.27	-82.83	-65.57	-60.14	-17.46	22.08	16.69	2.67	-4.53	2.67	1.86	-25.89
EPS Diluted	-68.14	-112.09	-187.85	-153.35	-127.27	-82.83	-65.57	-60.14	-17.46	21.95	16.69	2.67	-4.53	2.67	1.86	-25.89
Weighted Avg Shares Out	4.37M	4.37M	1.44M	2.02M	2.41M	2.84M	4.34M	4.35M	4.48M	5.68M	5.15M	46.07M	47.42M	48.68M	24.88M	19.16M
Weighted Avg Shares Out (Dil)	4.37M	4.37M	4.37M	4.37M	4.34M	4.34M	4.34M	4.35M	4.48M	4.51M	4.50M	46.07M	47.42M	48.68M	24.88M	19.16M

Concord Medical Purchases Additional Proton Therapy System for It's Shanghai Concord Cancer Center

September 10, 2021prnewswire.com

BEIJING, Sept. 10, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an...

Concord Medical Completes RMB 400 Million Funding Round Led by Consortium Investors

August 23, 2021prnewswire.com

BEIJING, Aug. 23, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializes in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an...

Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou

June 11, 2021prnewswire.com

BEIJING, June 11, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone...

Concord Medical Receives Notification from NYSE Regarding Delayed Filing of 2020 Annual Report

May 25, 2021prnewswire.com

BEIJING, May 25, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy...

Concord Medical Announces Changes in Board of Directors

May 21, 2021prnewswire.com

BEIJING, May 21, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone...

Concord Medical Announces Divestment of Singapore Concord International Hospital

December 28, 2020prnewswire.com

BEIJING, Dec. 28, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and...

Concord Medical Schedules 2020 Annual Meeting of Shareholders

November 20, 2020prnewswire.com

BEIJING, Nov. 20, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and...

For Monkey Knife Fight, The Value Of Merger With FantasyDraft May Come From Acquiring State Licenses

September 8, 2020forbes.com

The true value of Monkey Knife Fight's acquisition of daily fantasy sports company FantasyDraft likely comes in the form of securing additional licenses to operate its contests, most notably in New York.